![FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells | Leukemia FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.leu.2404510/MediaObjects/41375_2007_Article_BF2404510_Fig2_HTML.jpg)
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells | Leukemia
![PDF) High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study PDF) High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study](https://i1.rgstatic.net/publication/41419669_High-dose_imatinib_improves_cytogenetic_and_molecular_remissions_in_patients_with_pretreated_Philadelphia-positive_BCR-ABL-positive_chronic_phase_chronic_myeloid_leukemia_first_results_from_the_random/links/0912f50ca0d342b8fc000000/largepreview.png)
PDF) High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study
![Frontiers | Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy Frontiers | Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy](https://www.frontiersin.org/files/Articles/638689/fonc-11-638689-HTML-r1/image_m/fonc-11-638689-g001.jpg)
Frontiers | Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy
![Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia | NEJM Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1994/nejm_1994.330.issue-12/nejm199403243301204/production/images/img_medium/nejm199403243301204_f1.jpeg)
Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia | NEJM
![Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis | Request PDF Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis | Request PDF](https://i1.rgstatic.net/publication/303800842_Personal_history_and_quality_of_life_in_chronic_myeloid_leukemia_patients_a_cross-sectional_study_using_narrative_medicine_and_quantitative_analysis/links/5f74868e299bf1b53e006af4/largepreview.png)
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis | Request PDF
A 4.8mW inductorless CMOS frequency divider-by-4 with more than 60% fractional bandwidth up to 70GHz
![Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia | NEJM Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1994/nejm_1994.330.issue-12/nejm199403243301204/production/images/img_medium/nejm199403243301204_t1.jpeg)
Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia | NEJM
![Cancers | Free Full-Text | Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges | HTML Cancers | Free Full-Text | Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges | HTML](https://www.mdpi.com/cancers/cancers-13-04582/article_deploy/html/images/cancers-13-04582-g001.png)
Cancers | Free Full-Text | Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges | HTML
![PDF) Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty PDF) Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty](https://i1.rgstatic.net/publication/236783707_Bone_metabolism_growth_rate_and_pubertal_development_in_children_with_chronic_myeloid_leukemia_treated_with_imatinib_during_puberty/links/568f873408ae78cc0517afd4/largepreview.png)
PDF) Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty
![Clinical significance of neutrophil CD177 mRNA expression in Ph‐negative chronic myeloproliferative disorders - Passamonti - 2004 - British Journal of Haematology - Wiley Online Library Clinical significance of neutrophil CD177 mRNA expression in Ph‐negative chronic myeloproliferative disorders - Passamonti - 2004 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a3e8678c-81d5-467b-be71-25babb4d8c25/bjh.v194.2.cover.jpg)